USPTO serial 79345680
EDROP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- VAGHANI, MAYUR C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EDROP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPPO Box 34385Washington, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes; chemical preparations, enzymes, gene editing enzymes, DNA in the nature of biological preparations, RNA in the nature of biological preparations, oligonucleotides, genes in the nature of biological preparations and proteins for scientific and industrial purposes; chemical reagents for use in microfluidic processes for scientific and research purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA in the nature of biological preparations, synthetic RNA in the nature of biological preparations, synthetic genes in the nature of biological preparations, synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicals, reagents and enzymes for use in the preparation and creation of DNA, RNA, genes and proteins for scientific and research purposes; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial purposes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; biological, chemical and biochemical reagents, including DNA and RNA products, proteins and gene editing enzymes all for clinical diagnostic or medical use; synthetic DNA in the nature of biological preparations, synthetic RNA in the nature of biological preparations, synthetic genes in the nature of biological preparations, synthetic oligonucleotides in the nature of biological preparations and synthetic proteins in the nature of biological preparations for clinical or medical use; DNA and RNA products for medical use in the nature of biological preparations; therapeutic DNA and RNA products in the nature of biological preparations; vaccines | ACTIVE | — |
| 009 | Scientific laboratory apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis; microfluidic components and devices to be used for DNA, RNA, gene and protein synthesis, namely microfluidic manifolds, microfluidic chips and microfluidic cartridges and pumps in the nature of controlled volume pumps for laboratory or scientific research use in the life science field; microfluidic chips, being components of or for use in laboratory equipment and devices for DNA, RNA, gene, cell and protein synthesis and analysis; glassware for scientific laboratory use; tubes and connectors, namely electron tubes, electric connectors; instruments for scientific use in the preparation of liquids containing cells, namely microfluidic manifolds, microfluidic chips and microfluidic cartridges for laboratory or research use in the scientific field; laboratory apparatus for the dilution of liquids other than for medical use, namely microfluidic manifolds, microfluidic chips and microfluidic cartridges for laboratory or research use in the scientific field; laboratory apparatus for the dispensing of liquids other than for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges for laboratory or research use in the scientific field; laboratory apparatus for the incubation of liquids namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges for laboratory or research use in the scientific field; laboratory apparatus for the mixing of liquids, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges for laboratory or research use in the scientific field; laboratory apparatus for the transfer of liquids, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges for laboratory or research use in the scientific field; pumps for manipulating minute volumes of fluid in microfluidic systems for laboratory purposes, namely controlled volume pumps for the manipulation of liquids; controlled volume pumps for the extraction of liquids; measuring pumps for the extraction of liquids, gases or vapour, namely controlled volume pumps; connecting devices for data collection, namely optical fibre connectors; automated and laboratory apparatus and computer systems in the nature of microfluidic devices for use in the analysis of biomolecules, namely microarrays, scientific desktop instruments, desktop instrument cartridges for DNA, RNA, gene and protein synthesis, namely microfluidic devices, semiconductors, semiconductor chips, microchips, bio sensors for use in microfluidic devices, and bio-chips in the nature of microarrays, all for scientific laboratory use; scientific desktop instruments for DNA, RNA, gene and protein synthesis, namely microfluidic manifolds, microfluidic chips and microfluidic cartridges and pumps in the nature of controlled volume pumps for laboratory or scientific research use in the life science field; cartridges for DNA, RNA, gene and protein synthesis, namely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors for use in microfluidic devices, and bio-chips in the nature of microarrays; apparatus and instruments for amplifying DNA and RNA, namely polymerase chain reaction (PCR) apparatus; apparatus and instruments for synthesising DNA and RNA, namely microarrays, scientific desktop instruments, desktop instrument cartridges for DNA, RNA, gene and protein synthesis, namely microfluidic devices, semiconductors, semiconductor chips, microchips, bio sensors for use in microfluidic devices, and bio-chips in the nature of microarrays for laboratory or research use in the scientific field; apparatus and instruments for processing DNA and RNA, namely microarrays, scientific desktop instruments, desktop instrument cartridges for DNA, RNA, gene and protein synthesis, namely microfluidic devices, semiconductors, semiconductor chips, microchips, bio sensors for use in microfluidic devices, and bio-chips in the nature of microarrays for laboratory or research use in the scientific field; computer hardware, recorded computer software for data collection management and analysis of biological information; downloadable computer software and bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology and medical science | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, components and devices with microfluidic capabilities for use in genomic analysis for medical purposes; veterinary apparatus and instruments, namely, components and devices with microfluidic capabilities for use in genomic analysis for veterinary purposes; medical and veterinary apparatus and instruments for microfludic applications in the nature of silicon, polymer, metal, glass and microfluidic and micro-electromechanical chips, sensor chips, monitoring chips, biochips, flow cell chips, droplet generators, micromixers, micro reactors, flow cells from substrates of glass, metal, silicon, polymers, all for use in DNA and RNA analysis, sequencing and synthesis for medical and veterinary purposes; medical devices and instruments for measuring, analysing, controlling and regulating fluids for use in DNA and RNA analysis, sequencing and synthesis for medical and veterinary purposes; microfluidic devices for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges and pumps in the nature of controlled volume pumps for genomic analysis for medical and veterinary purposes; medical devices being components and devices with microfluidic capabilities for carrying out DNA and RNA analysis, sequencing and synthesis for medical and veterinary purposes; analytical devices for medical use, namely, microfluidic manifolds, microfluidic chips and microfluidic cartridges and pumps in the nature of controlled volume pumps for genomic analysis for medical or veterinary purposes; instruments for medical use in the form of microsensors, including microfluidic devices, microfluidic systems consisting primarily of microfluidic manifolds, microfluidic chips and microfluidic cartridges and pumps in the nature of controlled volume pumps and micro-network instruments, namely, silicon, polymer, metal, glass and microfluidic and micro-electromechanical chips, sensor chips, monitoring chips, biochips, flow cell chips, droplet generators, micromixers, micro reactors, flow cells from substrates of glass, metal, silicon, polymers, all for use in DNA and RNA analysis, sequencing and synthesis for medical and veterinary purposes; portable pump installations for liquids for medical use, namely, controlled volume pumps; tubing connectors for medical use; medical apparatus for use in separating liquids for medical use; microfluidic pumps for medical use in the extraction of liquids; measuring devices for medical use, namely, controlled volume pumps; fluid sampling apparatus for diagnostic medical use in the nature of components and devices with microfluidic capabilities, drug delivery devices in the nature of implantable drug delivery pumps; apparatus for analysing substances in liquids for medical use, in the nature of components and devices with microfluidic capabilities for medical and veterinary purposes, namely, microfluidic devices; apparatus and instruments for DNA and RNA analysis, sequencing and synthesis in the nature of components and devices with microfluidic capabilities for medical and veterinary purposes; apparatus for DNA, RNA, gene and protein synthesis in the nature of components and devices with microfluidic capabilities for use in medical analysis for medical and veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nuclera Ltd
- Other trademarks owned by Nuclera Ltd
- Other trademarks owned by Nuclera Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named EDROP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 15, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 20, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 20, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 1, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 1, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 1, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 1, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 1, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 31, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 30, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 30, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 30, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 2, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 1, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 15, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 28, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 6, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 9, 2023 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jan 6, 2023 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Dec 10, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 9, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2022 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Oct 30, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 27, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 26, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |